1 citations
,
July 2019 in “Case reports in dermatology” This case report describes the first known instance of loose anagen hair syndrome in a Southeast Asian child, a 13-year-old Thai boy with hair thinning and excessive shedding on the frontal scalp.
1 citations
,
May 2017 in “Journal of The American Academy of Dermatology” In this study, increasing cases of allergic contact dermatitis in Bulgaria were linked to the use of natural products like propolis and marigold.
1 citations
,
May 2017 in “Journal of The American Academy of Dermatology” This study found that the increasing use of natural products like propolis and calendula officinalis in Bulgaria is linked to a growing number of allergic contact dermatitis cases, predominantly in women.
1 citations
,
May 2016 in “Current Opinion in Pediatrics” This review discusses diagnostic strategies for pediatric hair loss, emphasizing the importance of thorough examinations and dermoscopy for accurate diagnosis, and reports no new research findings.
1 citations
,
September 2015 in “Clinics in Dermatology” This article provides a diagnostic guide for clinicians to differentiate between various hair shaft disorders by using a structured question-by-question approach but does not report new clinical findings.
1 citations
,
November 2014 This chapter reviews patchy hair loss due to skin disease, nail disorders related to chronic trauma, and treatments for small carcinomas, but it reports no new clinical findings.
July 2026 in “Frontiers in Pediatrics” In this case study, an 11-year-old girl with severe alopecia areata experienced complete hair regrowth and unexpected white-to-black hair repigmentation after switching from baricitinib to ritlecitinib, suggesting that prolonged Janus kinase inhibition may aid both hair and pigment restoration in severe pediatric cases.
This case report described a five-year-old girl with alopecia areata totalis who experienced significant hair regrowth after receiving dental rehabilitation for extensive untreated caries and chronic oral infection, suggesting a possible link between chronic oral infection and alopecia areata.
April 2026 in “International Journal of Homoeopathic Sciences” In this case report, individualized homeopathic treatment based on symptom totality led to anxiety reduction, halted lesion progression, and complete cosmetic recovery in a 30-year-old male with alopecia areata barbae, highlighting a potential area for further controlled studies.
March 2026 in “Clinical Cosmetic and Investigational Dermatology” In this case report, a 30-year-old woman with myasthenia gravis developed vitiligo and alopecia universalis during long-term rituximab therapy. Discontinuation of rituximab and initiation of oral baricitinib led to improvement in skin conditions, underscoring potential immune-related skin effects from rituximab.
February 2026 in “Psycho-Oncologie” This narrative review highlights that alopecia areata significantly impacts the psychological wellbeing of cancer patients, contributing to distress, anxiety, and depression, and underscores the importance of integrating dermatologic care with psycho-oncology to improve patient outcomes.
January 2026 in “Journal of Clinical and Investigative Dermatology” This case report describes a father with HOXC13-associated pure hair-nail ectodermal dysplasia, presenting with severe nail dystrophy affecting all digits and notable hypotrichosis or complete alopecia.
December 2025 in “Clinical Cosmetic and Investigational Dermatology” In this report, a unique female presentation of IFAP syndrome is described, featuring musculoskeletal contractures but no photophobia, highlighting the importance of early detection and multidisciplinary care to improve outcomes and prevent disability.
September 2025 in “Dermatology and Therapy” This study reviewed the burden of alopecia areata in the UAE, noting limited regional data on patient demographics and treatments but highlighting the approval and promising results of the Janus kinase inhibitor baricitinib for managing this condition.
August 2025 in “BMC Pregnancy and Childbirth” In this study, prenatal ultrasonography was found to be a valuable tool for screening ectodermal dysplasia during pregnancy, and a new EDA gene variant associated with X-linked hypohidrotic ectodermal dysplasia was identified, aiding in more accurate diagnoses and reproductive decision-making.
July 2025 in “Journal of Case Reports and Scientific Images” This study reports that a patient with severe, treatment-resistant alopecia areata experienced sustained hair regrowth and emotional improvement over 24 months following individualized homeopathic treatment, suggesting homeopathy may be a viable therapeutic option when conventional treatments fail.
This report describes a patient with X-linked hypohidrotic ectodermal dysplasia who lacked the usual hair growth issues, highlighting the challenge of diagnosing this condition due to atypical presentations and underscoring the need for awareness to improve management and future planning.
August 2024 in “International Journal of Basic & Clinical Pharmacology” This literature review examined research on hair follicle biology and hair loss treatments, highlighting the potential of secretome-based therapies, which may enhance hair regeneration and address limitations of treatments like minoxidil and finasteride.
January 2022 in “Acta dermatovenerologica Alpina, Pannonica et Adriatica (Tiskana izd.)” This article presents an overview of uncombable hair syndrome, emphasizing its clinical and molecular characteristics and noting systemic manifestations such as neuropsychiatric, ophthalmic, and cardiopulmonary issues.
May 2019 in “Small Animal Dermatology” This chapter reviews a case of colour dilution alopecia in a Dobermann, offering insights into the clinical progression, differential diagnoses, and treatment options but reports no new findings.
January 2019 in “Elsevier eBooks” This review discusses the evaluation methods for patients with hair loss, emphasizing the importance of history, physical examination, and, when necessary, laboratory tests or biopsy, but it reports no new clinical results.
January 2019 in “Springer eBooks” This review discusses drugs and mechanisms possibly responsible for chemical- and drug-induced hair loss but presents no new research findings.
May 2017 in “Journal of The American Academy of Dermatology” This study found an increase in allergic contact dermatitis cases linked to natural products like propolis and marigold, predominantly affecting women in a Bulgarian population.
May 2017 in “Journal of The American Academy of Dermatology” This study reported an increase in allergic contact dermatitis cases linked to natural products, particularly propolis and marigold, with a higher incidence in women than men.
July 2015 in “Cambridge University Press eBooks” The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.
February 2009 in “Journal of the American Academy of Dermatology” Transverse sections are better for non-scarring hair loss, vertical sections are better for lichen planopilaris, and either method works for other scarring hair loss types.
January 2008 in “Springer eBooks” Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.
May 2002 in “Dermatologic Surgery” This article describes a method for evaluating and treating the temporal peak regions in hair restoration surgery to achieve cosmetic harmony with the frontal hairline, while reporting no new clinical findings.
April 1940 in “Archives of dermatology” This abstract presents a case of arsenical dermatitis with pigmentation and alopecia developed during treatment with arsphenamine for a positive Wassermann reaction.
150 citations
,
April 1999 in “Dermatologic Clinics” This article reviews the biological and physical principles of laser hair removal and reports that current laser systems do not consistently achieve permanent hair follicle destruction across treated areas.